2018
Update on the Comprehensive Approach to Fragility Fractures
Cohn M, Gianakos A, Grueter K, Rosen N, Cong G, Lane J. Update on the Comprehensive Approach to Fragility Fractures. Journal Of Orthopaedic Trauma 2018, 32: 480-490. PMID: 30036208, DOI: 10.1097/bot.0000000000001244.Peer-Reviewed Original ResearchConceptsFragility fracturesAnabolic agentsDual-energy x-ray absorptiometry screeningFracture Liaison Service (FLS) modelNew anabolic agentsFirst-line treatmentFracture liaison serviceBone density lossAntiosteoporotic medicationAntiresorptive agentsNonpharmacologic treatmentsFracture careVitamin DSurgical historyTreatment optionsAntisclerostin antibodiesBone densityBone diseaseEffective treatmentLiaison servicePhysician extendersFracture healingPotential treatmentDensity lossTreatment
2016
Bisphosphonates, Denosumab, and Anabolic Agents in the Treatment of Metastatic Bone Disease
Olgun Z, Gianakos A, Jo J, Lane J. Bisphosphonates, Denosumab, and Anabolic Agents in the Treatment of Metastatic Bone Disease. 2016, 121-129. DOI: 10.1007/978-1-4614-5662-9_12.Peer-Reviewed Original Research